XML 20 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows (used in) provided by operating activities:    
Net income $ 166,996 $ 151,714
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of discount/premium and PIK (46,103) (15,491)
Amortization of deferred financing costs 8,204 4,464
Equity-based compensation 6,672 7,551
Unrealized gain on securities 0 (11,830)
Provision for loan losses and impairment 5,000 5,000
Loss from unconsolidated joint venture 0 2,259
Foreign currency (gain) loss 22,162 (16,940)
Unrealized (gain) loss on derivative instruments (20,986) 17,564
Loss on early extinguishment of debt 2,573 0
Realized loss on derivative instruments 0 289
Realized loss on sale of assets 0 5,118
Changes in operating assets and liabilities:    
Proceeds received from PIK 75,652 0
Other assets (8,476) (28,893)
Accounts payable, accrued expenses and other liabilities 8,087 (8,623)
Payable to related party 1,347 1,295
Net cash (used in) provided by operating activities 221,128 113,477
Cash flows used in investing activities:    
New funding of commercial mortgage loans (1,382,440) (505,323)
Add-on funding of commercial mortgage loans (90,201) (76,244)
New funding of subordinate loans (207,683) (365,500)
Add-on funding of subordinate loans (84,852) (110,003)
Proceeds and payments received on commercial mortgage loans 356,865 17,062
Proceeds and payments received on subordinate loans 463,524 221,478
Funding of derivative instruments 0 (201)
Origination and exit fees received on commercial mortgage and subordinate loans 32,473 13,047
Funding of unconsolidated joint venture 0 (726)
Funding of other assets 0 (1,379)
(Increase) decrease in collateral held related to derivative contracts 4,930 (14,262)
Payments and proceeds received on securities 0 288,781
Proceeds from sale of investments in unconsolidated joint venture 0 24,498
Net cash (used in) provided by investing activities (907,384) (508,772)
Cash flows from financing activities:    
Proceeds from issuance of common stock 275,879 249,021
Redemption of preferred stock 0 (86,250)
Payment of offering costs (199) (359)
Proceeds from secured debt arrangements 1,623,186 866,548
Repayments of secured debt arrangements (941,662) (727,691)
Proceeds from issuance of convertible senior notes 0 227,700
Exchanges and conversions of convertible senior notes (40,461) 0
Repayments of participations sold 0 (85,081)
Payment of deferred financing costs (11,545) (8,585)
Dividends on common stock (176,920) (136,404)
Dividends on preferred stock (20,505) (26,752)
Net cash (used in) provided by financing activities 707,773 272,147
Net increase (decrease) in cash and cash equivalents 21,517 (123,148)
Cash and restricted cash, beginning of period 77,671 263,453
Cash and restricted cash, end of period 99,188 140,305
Supplemental disclosure of cash flow information:    
Interest paid 77,219 44,303
Supplemental disclosure of non-cash financing activities:    
Exchange of convertible senior notes for common stock 178,567 0
Dividend declared, not yet paid 68,536 55,916
Offering costs payable $ 265 $ 41